# Gabapentin in Functional Dyspepsia Refractory to Proton Pump Inhibition

> **NCT01052896** · PHASE3 · WITHDRAWN · sponsor: **59th Medical Wing**

## Conditions studied

- Functional Dyspepsia

## Interventions

- **DRUG:** Gabapentin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01052896
- **Lead sponsor:** 59th Medical Wing
- **Sponsor class:** FED
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2010-03
- **Primary completion:** 2011-03
- **Final completion:** 2012-08-28
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Unable to recruit subjects - unworkable
- **Last updated:** 2020-10-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01052896

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01052896, "Gabapentin in Functional Dyspepsia Refractory to Proton Pump Inhibition". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01052896. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*